259 related articles for article (PubMed ID: 38571944)
1. Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia.
Pang Y; Holtzman NG
Best Pract Res Clin Haematol; 2023 Jun; 36(2):101475. PubMed ID: 37353287
[TBL] [Abstract][Full Text] [Related]
2. The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Maurer K; Soiffer RJ
Expert Rev Hematol; 2023; 16(12):943-962. PubMed ID: 37906445
[TBL] [Abstract][Full Text] [Related]
3. Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia.
Kinsella FAM; Maroto MAL; Loke J; Craddock C
Br J Haematol; 2024 Jun; 204(6):2173-2183. PubMed ID: 38602216
[TBL] [Abstract][Full Text] [Related]
4. Dermatologic complications in transplantation and cellular therapy for acute leukemia.
Babakoohi S; Gu SL; Ehsan H; Markova A
Best Pract Res Clin Haematol; 2023 Jun; 36(2):101464. PubMed ID: 37353285
[TBL] [Abstract][Full Text] [Related]
5. Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond.
Belbachir S; Abraham A; Sharma A; Prockop S; DeZern AE; Bonfim C; Bidgoli A; Li J; Ruggeri A; Bertaina A; Boelens JJ; Purtill D;
Cytotherapy; 2024 Jun; 26(6):546-555. PubMed ID: 38054912
[TBL] [Abstract][Full Text] [Related]
6. Navigating Treatment Options and Communication in Relapsed Pediatric AML.
Graff Z; Wachter F; Eapen M; Lehmann L; Cooper T
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438690. PubMed ID: 38862135
[TBL] [Abstract][Full Text] [Related]
7. Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic).
Ishii K; Barrett AJ
Ther Adv Hematol; 2016 Feb; 7(1):17-39. PubMed ID: 26834952
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
Loke J; Buka R; Craddock C
Front Immunol; 2021; 12():659595. PubMed ID: 34012445
[TBL] [Abstract][Full Text] [Related]
9. Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.
Murdock HM; Ho VT; Garcia JS
Front Immunol; 2024; 15():1359113. PubMed ID: 38571944
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation.
Tang Y; Zhou Z; Yan H; You Y
Front Immunol; 2022; 13():810284. PubMed ID: 35185899
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Alanazi W; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Mattsson J; Michelis FV
Acta Haematol; 2021; 144(1):66-73. PubMed ID: 32428903
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
14. Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor.
Ando T; Sano H; Yokoo M; Kusaba K; Kidoguchi K; Yamaguchi K; Katsuya H; Yoshihara S; Kubota Y; Kojima K; Kimura S
Int J Hematol; 2020 Aug; 112(2):249-253. PubMed ID: 32185622
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
